Stock Earnings Understanding the Risks of Investing in Nautilus Biotechnology Inc (NAUT) Nautilus Biotechnology Inc’s filing revealed that its Chief Scientist Mallick Parag acquired Company’s shares for reported $8788.0 on May 08
Stock Earnings NAUT Shares Experience Surge in Value Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nautilus Biotechnology